ARTICLE | Company News
RedPath, PDI deal
December 22, 2014 8:00 AM UTC
PDI acquired molecular diagnostics company RedPath for $12 million up front plus undisclosed milestones and up to 1 million PDI shares tied to the launch of a Barrett’s esophagus test. The terms of th...